On April 8, a bill was introduced into the Canadian House
of Commons that has highly worrisome implications for natural
health products and those who consume and use them. The same
implications might be in store for Americans as well.
Follow this link to the original source: "Canadian
Rights And Freedoms Are At Risk"
A newly proposed law in Canada, Bill C-51, just may outlaw
up to 60 percent of natural health products currently sold
in Canada — and criminalize people who use them. Bill
C-51 which makes significant changes to Canada’s Food
and Drugs Act, was introduced into the House of Commons by
the Canadian Minister of Health. The first reading on April
8 was followed by it’s second reading on April 28, barely
time for consumers, trade groups, and elected representatives
to examine, debate, or compose official positions.
Acts in Canada must pass three readings in both legislative
houses before becoming law. This is supposed to give representatives
and the general public time to become aware of any proposed
changes, have them debated, and give their consent. On the
other hand, Regulations are published in the newspaper twice
and can then be signed into law. Parliament does not vote
on Regulations. (Keep this bit in mind for later.)
(Article continues below)
The text of the lengthy bill describes many changes to be
made to Canada’s Food and Drugs Act and seems to have
left no stone unturned. The sweeping changes are couched in
the increasingly broad language we have come to expect from
bureaucratic governments. The language leaves the door wide
open for extreme governmental regulation, licensing, and enforcement
that would have devastating consequences on an entire industry
and millions of consumers.
One of the radical changes the proposed bill offers is in
terminology. The word "drug" will be replaced with
the term "therapeutic product." This one change
alone could effectively put all vitamins, herbs, supplements,
and even some foods under the complete control of the government.
The term "sell" would now include anyone who sells,
buys, or uses "therapeutic products," and anyone
who administers those products.
It will be the government’s delegates who will decide
on the regulation, licensing, marketing, inspecting, and enforcing
of all changes listed in the new bill. So it’s interesting
to note that the inspection and seizure powers in Bill C-51
are greatly expanded from the original Food and Drugs Act
that is presently enforced by Health Canada. Attorney Shawn
Buckley has done an excellent job dissecting and analyzing
C-51 (click on “Legal Review”) and has this to
say about the newly proposed inspection and seizure powers:
The inspecting and seizure powers found in s. 23 of the Act
are increased to: